![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR AND MOLECULAR
alInstitute of Physiology CAS, Prague, Czech Republic (P.M., V.D.); and University of Minnesota Medical School, Minneapolis, Minnesota (E.E.E.)
Muscarinic M2 receptors preferentially couple with the Gi/o class of G-proteins to inhibit cAMP synthesis. However, they can also stimulate net synthesis of cAMP and inositol phosphate (IP) accumulation. We investigated in intact Chinese hamster ovary (CHO) cells expressing human M2 receptors (CHO-M2 cells) whether direct interaction of M2 receptors with Gs and Gq/11 G-proteins is responsible for the latter effects. Suppression of the Gs
subunit using RNA interference abolished stimulation of cAMP synthesis induced by 1 mM carbachol in both control and pertussis toxin-treated CHO-M2 cells but had no effect on the inhibition of forskolin-stimulated cAMP synthesis. Carbachol stimulated accumulation of IP with an EC50 of 79 µM. Removal of the Gq,G11, or both
subunits reduced this response by 78, 54, and 92%, respectively, whereas suppression of the Gs
subunit had no effect. Similar results obtained in CHO cells expressing M1 receptors that preferentially couple with Gs and Gq/11 G-proteins confirmed the efficiency of siRNA treatments. Stimulation of M2 receptors in control and pertussis toxin-treated cells by a series of full agonists with respect to inhibition of adenylyl cyclase displayed different efficacies in stimulating IP accumulation. Carbachol, acetylcholine, and oxotremorine-M [N,N,N-trimethyl-4-(2-oxo-1-pyrolidinyl)-2-butyn-1-ammonium] behaved as full agonists, furmethide (N,N,N-trimethyl-2-furanmethammonium) and methylfurmethide [(5-methyl-2-furyl)methyltrimethylammonium] were partial agonists, and oxotremorine (1-[4-(1-pyrrolidinyl)-2-butynyl]-2-pyrrolidinone) had no effect. Our results provide direct evidence of M2 receptor coupling with the
subunits of Gs and Gq/11 G-proteins and demonstrate induction of multiple receptor conformational states dependent on both the concentration and the nature of the agonist used.
Address correspondence to: V. Dole
al, Department of Neurochemistry, Institute of Physiology CAS, Víde
ská 1083, 14220 Prague, Czech Republic. E-mail: dolezal{at}biomed.cas.cz
This article has been cited by other articles:
![]() |
M. T. Griffin, K. W. Figueroa, S. Liller, and F. J. Ehlert Estimation of Agonist Activity at G Protein-Coupled Receptors: Analysis of M2 Muscarinic Receptor Signaling through Gi/o,Gs, and G15 J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1193 - 1207. [Abstract] [Full Text] [PDF] |
||||